Intrapericardial therapeutics: A pharmacodynamic and pharmacokinetic comparison between pericardial and intravenous procainamide delivery

被引:20
|
作者
Ujhelyi, MR
Hadsall, KZ
Euler, DE
Mehra, R
机构
[1] Medtron CRM Res, Minneapolis, MN 55432 USA
[2] Univ Minnesota, Coll Pharm, Minneapolis, MN 55455 USA
关键词
pericardium; procainamide; pharmacokinetics; atrial fibrillation; ventricular fibrillation; electrophysiology; antiarrhythmic therapy; conduction velocity; refractory period;
D O I
10.1046/j.1540-8167.2002.00605.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction: Procainamide delivery into the pericardial space may produce a greater and more prolonged electrophysiologic effect, particularly in thin superficial atrial tissue, compared with intravenous delivery. Methods and Results: Swine were randomized to sequential procainamide doses delivered intravenously (n = 6) or into the pericardial space (n = 7). The cumulative pericardial doses were 0.5, 1.5, and 3.5 mg/kg, and the intravenous doses were 2, 10, and 26 mg/kg. Pericardial procainamide prolonged right atrial effective refractory period from baseline by 22% (P < 0.01) but only at the 3.5 mg/kg cumulative dose. This dose slowed interatrial conduction time by 14% (P < 0.05) and raised atrial fibrillation threshold by 70 mA (P < 0.05). Pericardial procainamide had minimal effect on ventricular electrophysiology. Similar results occurred with a single 2 mg/kg pericardial dose in a closed chest model. Intravenous 10 and 26 mg/kg cumulative doses prolonged atrial effective refractory period from baseline by 24% and 18% (P < 0.01), respectively. The 26 mg/kg cumulative intravenous dose slowed interatrial and atrial-ventricular conduction times by 27% and 17%, respectively (P < 0.05), raised atrial fibrillation threshold, and slowed ventricular conduction time by 29% (P < 0.05). Pericardial procainamide produced pericardial fluid concentrations ranging from 250 to 1,500 mug/mL, but plasma concentrations were <1 mug/mL. Intravenous procainamide doses produced pericardial fluid concentrations similar to plasma trough concentrations 0 to 12 mug/mL. Conclusion: The single 2 mg/kg and 3.5 mg/kg cumulative pericardial procainamide doses prolonged atrial refractoriness and raised atrial fibrillation threshold similar to the 26 mg/kg cumulative intravenous dose, but the duration of effect was similar between delivery methods. Pericardial procainamide did not affect global or endocardial ventricular electrophysiology nor was it associated with ventricular proarrhythmia.
引用
收藏
页码:605 / 611
页数:7
相关论文
共 41 条
  • [1] PHARMACOKINETIC-PHARMACODYNAMIC RELATIONSHIPS OF INTRAVENOUS PROCAINAMIDE IN NORMALS
    BOUDOULAS, H
    COYLE, JD
    LIMA, JJ
    MACKICHAN, JJ
    LEWIS, RP
    JOURNAL OF CLINICAL PHARMACOLOGY, 1985, 25 (06): : 474 - 474
  • [2] PHARMACOKINETIC-PHARMACODYNAMIC RELATIONSHIPS OF INTRAVENOUS PROCAINAMIDE IN NORMALS
    BOUDOULAS, H
    COYLE, JD
    LIMA, JJ
    MACKICHAN, JJ
    LEWIS, RP
    CLINICAL RESEARCH, 1984, 32 (04): : A777 - A777
  • [3] COMPARISON OF THE PHARMACOKINETIC AND PHARMACODYNAMIC PROPERTIES OF PROCAINAMIDE AND N-ACETYLPROCAINAMIDE
    ATKINSON, AJ
    RUO, TI
    PIERGIES, AA
    ANGIOLOGY, 1988, 39 (07) : 655 - 667
  • [4] Pharmacokinetic and Pharmacodynamic Comparison of Intravenous and Inhaled Caspofungin
    Yu, Iching G.
    O'Brien, Sean E.
    Ryckman, David M.
    JOURNAL OF AEROSOL MEDICINE AND PULMONARY DRUG DELIVERY, 2021, 34 (03) : 197 - 203
  • [5] A pharmacodynamic and pharmacokinetic comparison of intravenous quinaprilat and oral quinapril
    Breslin, E
    Posvar, E
    Neub, M
    Trenk, D
    Jahnchen, E
    JOURNAL OF CLINICAL PHARMACOLOGY, 1996, 36 (05): : 414 - 421
  • [6] COMPARISON OF INTRAVENOUS AND ENDOBRONCHIAL ATROPINE - A PHARMACOKINETIC AND PHARMACODYNAMIC STUDY IN PIGS
    HORNCHEN, U
    SCHUTTLER, J
    STOECKEL, H
    ENSING, K
    DEZEEUW, RA
    EICHELKRAUT, W
    EUROPEAN JOURNAL OF ANAESTHESIOLOGY, 1989, 6 (02) : 95 - 102
  • [7] Pharmacokinetic and pharmacodynamic interactions between intravenous ciprofloxacin and oral ferrous sulfate
    Wong, PY
    Zhu, M
    Li, RC
    JOURNAL OF CHEMOTHERAPY, 2000, 12 (04) : 286 - 293
  • [8] PHARMACOKINETIC-HEMODYNAMIC INTERACTIONS BETWEEN VASOPRESSIN AND NITROGLYCERIN - COMPARISON BETWEEN INTRAVENOUS AND CUTANEOUS ROUTES OF NITRATE DELIVERY
    BLEI, AT
    FRIEDMAN, S
    GOTTSTEIN, J
    ROBERTSON, G
    FUNG, HL
    HEPATOLOGY, 1985, 5 (02) : 264 - 270
  • [9] Comparison of the pharmacokinetic, pharmacodynamic, and safety profiles of three different formulations of intravenous epoprostenol sodium
    Nicolas, Laurent
    Gutierrez, Marcelo
    Dingemanse, Jasper
    EUROPEAN RESPIRATORY JOURNAL, 2012, 40
  • [10] Pharmacokinetic differences between subcutaneous injection and intradermal microneedle delivery of protein therapeutics
    Koenitz, Laura
    Crean, Abina
    Vucen, Sonja
    EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2024, 204